LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY

It was found that soluble intercellular adhesion molecule-1 (ICAM-1) and leukocyte levels in patients with non-ST elevation acute coronary syndrome exhibited a gradual decrease during follow-up period of 6 to 12 months after CABG, as compared with pre-treatment baseline rates. In addition, sICAM-1 l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: N. A. Gavricheva, K. V. Korzhenevskaya, G. V. Alekseeva, A. V. Panov
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2014
Materias:
Acceso en línea:https://doaj.org/article/701004a954794b6d80722098294acc23
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:701004a954794b6d80722098294acc23
record_format dspace
spelling oai:doaj.org-article:701004a954794b6d80722098294acc232021-11-18T08:03:43ZLONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY1563-06252313-741X10.15789/1563-0625-2014-2-183-188https://doaj.org/article/701004a954794b6d80722098294acc232014-08-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/684https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XIt was found that soluble intercellular adhesion molecule-1 (ICAM-1) and leukocyte levels in patients with non-ST elevation acute coronary syndrome exhibited a gradual decrease during follow-up period of 6 to 12 months after CABG, as compared with pre-treatment baseline rates. In addition, sICAM-1 level showed an increase at 48 month post-CABG, tending to pre-treatment values. The levels of tumor necrosis factor-alpha (TNFa) and interleukin-6 (IL-6) did not express any significant changes during the entire observation period. TNFα level in the patients with non-STEMI before surgery did not differ from the levels in the patients with stable ischemic heart disease (60.0±9.8 pg/ml and 51.0±6.8 pg/ml; p > 0.05). Serum TNFα level remained unchanged in the patients after CABG. Similar changes were found for IL-6, with no differences between initial levels in the patients with non-STEMI and those with stable coronary artery disease (34.5±3.6 pg/ml and 28.6±3.1 pg/ml; p > 0.05). The IL-6 levels remained virtually unchanged over the observation time. Therefore, the ambiguous results obtained in present study deserve further studies of the role of inflammatory mediators in different clinical forms of ischemic heart disease following CABG.N. A. GavrichevaK. V. KorzhenevskayaG. V. AlekseevaA. V. PanovSPb RAACIarticleacute coronary syndromecoronary bypassintercellular adhesion molecule-1proinflammatory cytokinesleukocytesImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 16, Iss 2, Pp 183-188 (2014)
institution DOAJ
collection DOAJ
language RU
topic acute coronary syndrome
coronary bypass
intercellular adhesion molecule-1
proinflammatory cytokines
leukocytes
Immunologic diseases. Allergy
RC581-607
spellingShingle acute coronary syndrome
coronary bypass
intercellular adhesion molecule-1
proinflammatory cytokines
leukocytes
Immunologic diseases. Allergy
RC581-607
N. A. Gavricheva
K. V. Korzhenevskaya
G. V. Alekseeva
A. V. Panov
LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY
description It was found that soluble intercellular adhesion molecule-1 (ICAM-1) and leukocyte levels in patients with non-ST elevation acute coronary syndrome exhibited a gradual decrease during follow-up period of 6 to 12 months after CABG, as compared with pre-treatment baseline rates. In addition, sICAM-1 level showed an increase at 48 month post-CABG, tending to pre-treatment values. The levels of tumor necrosis factor-alpha (TNFa) and interleukin-6 (IL-6) did not express any significant changes during the entire observation period. TNFα level in the patients with non-STEMI before surgery did not differ from the levels in the patients with stable ischemic heart disease (60.0±9.8 pg/ml and 51.0±6.8 pg/ml; p > 0.05). Serum TNFα level remained unchanged in the patients after CABG. Similar changes were found for IL-6, with no differences between initial levels in the patients with non-STEMI and those with stable coronary artery disease (34.5±3.6 pg/ml and 28.6±3.1 pg/ml; p > 0.05). The IL-6 levels remained virtually unchanged over the observation time. Therefore, the ambiguous results obtained in present study deserve further studies of the role of inflammatory mediators in different clinical forms of ischemic heart disease following CABG.
format article
author N. A. Gavricheva
K. V. Korzhenevskaya
G. V. Alekseeva
A. V. Panov
author_facet N. A. Gavricheva
K. V. Korzhenevskaya
G. V. Alekseeva
A. V. Panov
author_sort N. A. Gavricheva
title LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY
title_short LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY
title_full LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY
title_fullStr LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY
title_full_unstemmed LONG-TERM CHANGES OF INFLAMMATION MARKERS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROME FOLLOWING CORONARY ARTERY BYPASS GRAFTING SURGERY
title_sort long-term changes of inflammation markers in patients with non-st elevation acute coronary syndrome following coronary artery bypass grafting surgery
publisher SPb RAACI
publishDate 2014
url https://doaj.org/article/701004a954794b6d80722098294acc23
work_keys_str_mv AT nagavricheva longtermchangesofinflammationmarkersinpatientswithnonstelevationacutecoronarysyndromefollowingcoronaryarterybypassgraftingsurgery
AT kvkorzhenevskaya longtermchangesofinflammationmarkersinpatientswithnonstelevationacutecoronarysyndromefollowingcoronaryarterybypassgraftingsurgery
AT gvalekseeva longtermchangesofinflammationmarkersinpatientswithnonstelevationacutecoronarysyndromefollowingcoronaryarterybypassgraftingsurgery
AT avpanov longtermchangesofinflammationmarkersinpatientswithnonstelevationacutecoronarysyndromefollowingcoronaryarterybypassgraftingsurgery
_version_ 1718422425729761280